Immunoglobulins

By /
Structural Architecture, Proteolysis & Isotype Biology of Immunoglobulins

Structural Architecture, Proteolysis & Isotype Biology of Immunoglobulins

Antibody Domains · Fab/Fc Fragments · IgG · IgM · IgA · IgD · IgE

1. Structural Architecture of Immunoglobulins

Immunoglobulins (antibodies) are specialized, antigen-binding glycoproteins belonging to the immunoglobulin superfamily. They are synthesized exclusively by B cells and exist in two distinct functional forms: soluble antibodies (secreted into blood plasma, mucosal secretions, and tissue interstitial fluid) and membrane-bound antibodies (which serve as the antigen-specific B-cell receptor on the cell membrane). Secreted and membrane-bound immunoglobulins constitute the bulk of the gamma globulin fraction of blood proteins.

Polypeptide Chain Composition

A monomeric antibody molecule is a Y-shaped, bivalent heterodimer composed of four polypeptide chains:

  • Chain 1
    Two Identical Light (L) Chains

    Each chain consists of approximately 220 amino acids with a molecular mass of roughly 25,000 Da.

  • Chain 2
    Two Identical Heavy (H) Chains

    Each chain consists of approximately 440 amino acids with a molecular mass of roughly 50,000 Da.

The polypeptide chains are held together by covalent interchain disulfide bonds (linking the light chains to the heavy chains, and the two heavy chains to each other). The overall structure can be viewed as a dimer of H–L heterodimeric units.

The Immunoglobulin Domain (Ig Fold)

Both light and heavy chains consist of repeating structural units, each about 110 amino acids in length. These units fold independently into a characteristic globular motif termed the immunoglobulin (Ig) domain.

  • Feature
    Secondary Structure

    An Ig domain is composed of two β-pleated sheets, where each sheet consists of three to five antiparallel β-strands.

  • Feature
    Stabilization

    The two β-pleated sheets are held together and stabilized by an internal intradomain disulfide bridge.

Variable (V) and Constant (C) Regions

The amino acid sequences of both light and heavy chains reveal two distinct regions:

  • V Region
    Variable (V) Regions

    Located at the amino-terminal (N-terminal) end of the chains. The variable region of one light chain (VL, consisting of one Ig domain) and the variable region of one heavy chain (VH, consisting of one Ig domain) pair to form a single, bivalent antigen-binding site.

  • C Region
    Constant (C) Regions

    Located at the carboxy-terminal (C-terminal) end of the chains. The constant region of a light chain (CL) consists of a single Ig domain. The constant region of a heavy chain (CH) is composed of three or four Ig domains (labeled CH1, CH2, CH3, and sometimes CH4). The C region domains do not participate directly in antigen recognition but are responsible for mediating effector functions (such as complement activation and Fc receptor binding).

VARIABLE REGION (N-TERMINUS) — ANTIGEN RECOGNITION ANTIGEN-BINDING SITE ANTIGEN-BINDING SITE VH CDR1–3 loops VL CDR1–3 loops CH1 Fab constant CL κ or λFAB ARM (Fragment, antigen-binding) VH CDR1–3 loops VL CDR1–3 loops CH1 Fab constant CL κ or λ S–S S–SFAB ARM (Fragment, antigen-binding) FRAGMENT CRYSTALLIZABLE (Fc) HINGE Pro-rich · inter-H S–S CH2 N-glycosylation site CH3 H–H homodimer (S–S)C-TERMINUS Fc: complement fixation · Fc-receptor binding

Figure: Domain Architecture of an IgG Monomer. Two heavy chains (blue, VH–CH1–hinge–CH2–CH3) and two light chains (green, VL–CL) pair through non-covalent contacts and interchain disulfide bonds (S–S). Each arm's paired VH and VL domains form one antigen-binding site; the three hypervariable Complementarity Determining Regions (CDR1–3) on each V domain project from a conserved Framework Region (FR) scaffold to build the paratope. The proline-rich hinge (crimson) joins the two Fab arms to the Fc trunk and carries the disulfide bonds linking the two heavy chains.

Hypervariable Regions (CDRs) and Framework Regions (FRs)

The variability in the variable domains is not distributed uniformly. Instead, it is concentrated within three small, highly variable loops termed Complementarity Determining Regions (CDRs): CDR1, CDR2, and CDR3.

  • CDR Loops
    Length & Variability

    Each CDR is approximately 10 amino acid residues in length. The CDR3 loop is the most variable of the three, as its sequence is determined by the junctional joining of gene segments.

  • Framework
    Framework Regions (FRs)

    The relatively conserved regions of the variable domains that separate the CDRs and provide the structural scaffolding for the β-sheet fold are called Framework Regions (FRs).

Structural Flexibility (The Hinge Region)

Antibody molecules are highly flexible. This mobility is conferred by a specialized hinge region located between the CH1 and CH2 domains.

  • Composition
    Proline & Cysteine Rich

    The hinge region is rich in proline residues (conferring flexibility) and cysteine residues (participating in inter-heavy chain disulfide bonds).

  • Distribution
    Present / Absent by Isotype

    The hinge region is present in γ, δ, and α heavy chains (IgG, IgD, and IgA), but is absent in μ and ε chains (IgM and IgE). The μ and ε heavy chains contain an extra constant domain (CH4) in place of a hinge region.

Secreted vs. Membrane-Bound Carboxy Termini

The structural difference between secreted and membrane-bound immunoglobulins resides entirely within the C-terminal portion of the heavy chain:

Secreted Antibodies

Possess a hydrophilic C-terminal amino acid sequence that allows the molecule to remain soluble in body fluids.

Membrane-Bound Antibodies

Contain a C-terminal region divided into three distinct segments:

  • An extracellular hydrophilic spacer sequence.
  • A hydrophobic transmembrane sequence that anchors the antibody in the lipid bilayer of the B-cell membrane.
  • A short cytoplasmic tail extending into the cytoplasm.

2. Classical Proteolytic Cleavage & Reduction Experiments

The structural organization of the immunoglobulin molecule was historically deduced using selective enzymatic cleavage and chemical reduction experiments:

Papain Digestion (Porter)

The proteolytic enzyme papain cleaves the heavy chains of an IgG molecule in the hinge region just above the inter-heavy chain disulfide bonds.

  • Product 1 & 2
    Two Fab Fragments

    Fragment Antigen Binding. Monovalent fragments (~45,000–50,000 Da each) consisting of a complete light chain and the VH and CH1 domains of the heavy chain. They retain the ability to bind antigen but cannot cross-link or precipitate antigens.

  • Product 3
    One Fc Fragment

    Fragment Crystallizable. A homodimer (~45,000–50,000 Da) composed of the C-terminal constant domains (CH2 and CH3) of both heavy chains held together by disulfide bonds. Does not bind antigen but spontaneously forms crystals and mediates effector functions (complement fixation, cell-surface receptor binding).

Pepsin Digestion (Nisonoff)

The proteolytic enzyme pepsin cleaves the heavy chains below the inter-heavy chain disulfide bonds in the hinge region.

  • Product 1
    One F(ab')2 Fragment

    A single, large, bivalent fragment (~100,000 Da) consisting of the two antigen-binding arms held together by interchain disulfide bonds. Because it possesses two antigen-binding sites, it is bivalent and can cross-link and precipitate antigens.

  • Product 2
    Degraded Fc Fragments

    The Fc portion is completely digested and degraded into multiple small peptide fragments, which fail to precipitate or mediate effector functions.

Mercaptoethanol Reduction (Edelman)

Treating IgG with the reducing agent β-mercaptoethanol breaks the covalent disulfide bonds holding the polypeptide chains together.

  • Products
    Free Heavy & Light Chains

    When followed by alkylation (to prevent the spontaneous reformation of disulfide bonds), reduction resolves the IgG molecule into two identical heavy chains (~50,000 Da each) and two identical light chains (~22,000 Da each).

PAPAIN (Porter) cuts above inter-H S–S Fab ~45–50 kDa Fab ~45–50 kDa Fc ~45–50 kDa 2 monovalent Fab + 1 crystallizable Fc (cannot precipitate antigen) PEPSIN (Nisonoff) cuts below inter-H S–S F(ab')2 ~100 kDa · bivalent Fc → degraded into small peptides 1 bivalent F(ab')2 Fc portion destroyed (can still precipitate antigen) β-MERCAPTOETHANOL + Alkylation (Edelman) ✕ ✕ ✕ reduces & blocks all S–S 2 × Heavy chain ~50 kDa each 2 × Light chain ~22 kDa each Fully dissociated chains (alkylation prevents re-forming S–S)

Figure: Classical Proteolytic & Reductive Dissection of IgG. Papain cleaves above the inter-heavy-chain disulfide bonds, releasing two monovalent Fab fragments and one crystallizable Fc fragment. Pepsin cleaves below these disulfide bonds, keeping the two antigen-binding arms joined as a single bivalent F(ab')₂ fragment while the Fc portion is degraded into small peptides. β-Mercaptoethanol reduces every disulfide bond; subsequent alkylation blocks their re-formation, fully separating the molecule into two heavy chains and two light chains.

3. Structural and Biological Characteristics of Antibody Isotypes

In mammals, there are five major classes, or isotypes, of immunoglobulins: IgG, IgM, IgA, IgD, and IgE. The class of an antibody is determined by the constant region of its heavy chain, designated by Greek letters: γ (IgG), μ (IgM), α (IgA), δ (IgD), and ε (IgE).

All species express two major classes of light chains: κ (kappa) and λ (lambda). Any individual antibody molecule contains either two identical κ light chains or two identical λ light chains, but never one of each.

Detailed Comparison of Mammalian Immunoglobulin Isotypes

Feature / PropertyIgGIgAIgMIgDIgE
Heavy Chain Typeγ (γ1, γ2, γ3, γ4)α (α1, α2)μδε
Molecular Weight (×10³ Da)150150 (monomer), 400 (dimer)900 (pentamer)180190
Heavy–Light Units / Molecule11 (monomer), 2 (dimer)5 (pentamer)11
Secreted State / ValenceMonomer (valency: 2)Dimer / tetramer (valency: 4)Pentamer (valency: 10)Monomer (valency: 2)Monomer (valency: 2)
Percentage of Total Serum Ig~80%10–15%5–10%<1%<1%
Serum Half-life (Days)~23 (IgG3 is ~7)~5.5~5~2.8~2
Carbohydrate Content (%)3%7%7–10%12%11%
Additional Protein SubunitsNoneJ-chain & Secretory ComponentJ-chainNoneNone
Crosses PlacentaYesNoNoNoNo
Enters SecretionsYesYes (+++)NoNoNo
Agglutination EfficiencyModerateModerateHigh (+++)NoneNone
Complement ActivationModerate (++)NoHigh (++++)NoNo
Binds Macrophage / Neutrophil FcYesNoNoNoNo
Binds Mast Cell / Basophil FcNoNoNoNoYes (+)
IgG — MONOMER Valency = 2 No accessory chains Only isotype to cross placenta Secretory IgA — DIMER J Secretory Component Valency = 4 Dominant Ig of mucosal secretions IgM — PENTAMER J Valency = 10 First Ig produced (B cells & neonate) Most efficient complement activator

Figure: Secreted Immunoglobulin Architectures. IgG is secreted as a single Y-shaped monomer (valency 2). Secretory IgA is a J-chain-linked dimer stabilized by the Secretory Component acquired during transcytosis across mucosal epithelium (valency 4). IgM is secreted as a J-chain-linked pentamer of five monomeric units (valency 10), whose high avidity makes it exceptionally efficient at agglutination and classical complement activation.

Detailed Functional Profiles

  • IgG
    Most Abundant Serum Isotype
    • Accounts for roughly 80% of circulating immunoglobulins; divided into four subclasses (IgG1, IgG2, IgG3, IgG4, in decreasing order of serum abundance) based on minor γ heavy chain sequence differences.
    • Placental Transfer: the only antibody class capable of crossing the placenta, providing passive immunity to the developing fetus.
    • Opsonization & Complement: binds macrophage and neutrophil Fc receptors to enhance phagocytosis (opsonization) and is a moderate activator of the classical complement cascade.
    • Half-life: the longest of all isotypes (~23 days, except IgG3 at ~7 days).
  • IgM
    First Responder Isotype
    • The first class of antibody produced by developing B cells and the first class secreted during a primary immune response; also the first antibody synthesized by the neonate.
    • Structure: a monomer on the B-cell membrane; secreted as a pentamer of five monomeric units covalently linked by disulfide bonds and a single B-cell-synthesized J-chain (~15 kDa).
    • Complement Activation: its pentameric structure gives a valency of 10, making it exceptionally efficient at agglutinating particulate antigens and activating the classical complement pathway, which requires two closely positioned Fc domains to initiate.
  • IgA
    Dominant Mucosal Isotype
    • Constitutes 10–15% of total serum immunoglobulins but is the predominant antibody class in external secretions (colostrum, breast milk, saliva, tears, and mucus of the respiratory, genitourinary, and digestive tracts). Two human subclasses: IgA1 and IgA2.
    • Transcytosis & Secretory Component: serum IgA is predominantly monomeric, but secretory IgA (sIgA) exists as a J-chain-linked dimer. Dimeric IgA binds the poly-Ig receptor on the basal membrane of mucosal epithelial cells, is endocytosed and transcytosed to the apical membrane, where the receptor is proteolytically cleaved — releasing dimeric IgA still bound to a receptor fragment termed the Secretory Component, which stabilizes sIgA and protects it from proteolytic degradation in hostile mucosal environments.
  • IgE
    Allergic & Anti-Parasitic Isotype
    • Present in extremely low serum concentrations (<1%) but mediates powerful physiological responses.
    • Allergic Responses: binds with exceptionally high affinity to Fc receptors (FcεR) on circulating blood basophils and tissue-resident mast cells. Cross-linking of receptor-bound IgE by an antigen (allergen) triggers immediate degranulation, releasing vasoactive amines (such as histamine) that cause allergy, asthma, and anaphylactic shock.
    • Anti-parasitic Defense: IgE-mediated mast cell degranulation and leukocyte activation play an essential role in defending the host against protozoan and helminthic parasites.
  • IgD
    Naive B-Cell Receptor
    • Accounts for only ~0.2% of total serum immunoglobulins. Together with monomeric IgM, IgD is co-expressed on the surface of mature, naive B cells.
    • Function: thought to function as a cell-surface receptor signaling B-cell activation. It has no major known soluble biological effector functions.

4. Antigenic Determinants on Antibodies

Because antibodies are glycoproteins, they can themselves serve as immunogens and induce an immune response when introduced into a foreign host. Antigenic determinants (epitopes) on antibody molecules are categorized into three classes.

ANTIGENIC DETERMINANTS ON IMMUNOGLOBULINS ISOTYPIC (Constant Region) Shared by all members of the species Defines H-chain class (γ μ α δ ε) & L type (κ λ) ALLOTYPIC (Constant Region) Allelic variants within the species e.g., strain A vs strain B antibodies (same species) IDIOTYPIC (Variable Region) Clone-specific — the antigen-binding site Unique per clone (idiotope → idiotype)

Figure: The Three Classes of Antigenic Determinants on Immunoglobulins. Isotypic and allotypic determinants both reside in the constant region — isotypic determinants are shared by every member of the species, while allotypic determinants reflect allelic differences between individuals. Idiotypic determinants reside in the variable region's hypervariable loops and are unique to each individual antibody-producing clone.

Isotypic Determinants

Isotypic determinants are antigenic constant-region features of the heavy and light chains that characterize all members of a given species.

  • Isotypic
    Constant-Region, Species-Wide
    • Definition: they define the class (isotype) of the heavy chain (γ, μ, α, δ, ε) and the class of the light chain (κ, λ).
    • Immunogenicity: if human IgM is injected into a rabbit, the rabbit recognizes the human constant regions as foreign and produces anti-human isotypic antibodies.

Allotypic Determinants

Allotypic determinants are antigenic variations in the constant regions of heavy and light chains that reflect genetic (allelic) differences among individuals of the same species.

  • Allotypic
    Constant-Region, Individual-Specific
    • Definition: they arise from alternative allelic forms (allotypes) of the same isotype genes.
    • Immunogenicity: injecting antibodies from a mouse of strain A into a genetically different mouse of strain B of the same species can induce anti-allotypic antibodies.

Idiotypic Determinants

Idiotypic determinants are unique antigenic features localized specifically within the hypervariable (CDR) domains of the variable (VH and VL) regions.

  • Idiotypic
    Variable-Region, Clone-Specific
    • Definition: an individual antigenic determinant in the variable region is called an idiotope. The sum of all idiotopes on a single antibody molecule constitutes its idiotype.
    • Immunogenicity: idiotypes are clone-specific and correspond directly to the antigen-binding site. Injecting a highly purified monoclonal antibody from mouse 1 of strain A into a genetically identical mouse 2 of strain A will induce anti-idiotypic antibodies, because the specific antigen-binding site of that clone is recognized as unique.

5. Germ-Line Organization of Immunoglobulin Genes

To produce a virtually limitless array of antigen-specific receptors, the vertebrate immune system rearranges germ-line DNA. In germ-line DNA, multiple gene segments encode portions of a single immunoglobulin heavy or light chain. During B-cell maturation in the bone marrow, these gene segments are recombined to generate functional variable-region exons.

Light Chain Gene Loci

The κ Light Chain Locus (Human Chromosome 2). The κ light chain variable region is constructed from two gene segments: a variable (Vκ) segment and a joining (Jκ) segment.

  • κ Locus
    Structure

    In humans, the locus consists of approximately 40 linear Vκ segments (each preceded by its own L, or leader, sequence), a downstream cluster of 5 Jκ segments, and a single Cκ constant gene segment.

The λ Light Chain Locus (Human Chromosome 22). The λ light chain is also constructed from Vλ and Jλ segments.

  • λ Locus
    Structure

    In humans, the locus contains approximately 30 Vλ segments. Downstream of these segments lies a series of four or five distinct pairs of Jλ–Cλ segments (where each Cλ gene is preceded by its own corresponding Jλ segment).

V segment J segment C gene κ LIGHT CHAIN LOCUS — HUMAN CHROMOSOME 2 ≈40 × L–Vκ segments intervening DNA 5 × Jκ segments Cκ (1 gene) Vκ–Jκ RECOMBINATION λ LIGHT CHAIN LOCUS — HUMAN CHROMOSOME 22 ≈30 × L–Vλ segments Jλ1 Cλ1 Jλ2 Cλ2 Jλ3 Cλ3 Jλ4 Cλ5 4–5 × Jλ–Cλ PAIRSFunctional L chain = one Vλ + one Jλ, spliced to that Jλ's own downstream Cλ

Figure: Germline Organization of the Human κ and λ Light Chain Loci. The κ locus (chromosome 2) carries ~40 Vκ segments, a single downstream cluster of 5 Jκ segments, and one Cκ gene — any one Vκ can recombine with any one Jκ, and the resulting exon is always spliced to the same Cκ. The λ locus (chromosome 22) carries ~30 Vλ segments upstream of 4–5 separate Jλ–Cλ pairs, so each rearranged Vλ–Jλ exon is spliced to the particular Cλ that follows the Jλ segment used.

Heavy Chain Gene Locus (Human Chromosome 14)

Unlike light chains, the heavy chain variable region is constructed from three distinct gene segments: a variable (VH) segment, a diversity (DH) segment, and a joining (JH) segment.

  • Heavy Locus
    Structure

    In humans, the locus consists of approximately 50 VH segments, a downstream cluster of approximately 20 DH segments, a cluster of 6 JH segments, and a downstream array of Constant (CH) region genes arranged in a defined developmental order: μ – δ – γ3 – γ1 – γ2b – γ2a – ε – α.

HEAVY CHAIN LOCUS — HUMAN CHROMOSOME 14 ≈50 × VH segments ≈20 × DH segments 6 × JH segments Cμ Cδ Cγ3 Cγ1 Cγ2b Cγ2a Cε Cα CONSTANT REGION GENES — FIXED DEVELOPMENTAL ORDER VH–DH–JH RECOMBINATIONClass switching later exchanges the rearranged VHDJH exon onto a downstream CH gene without altering antigen specificity (e.g., IgM → IgG). V segment D segment J segment C gene

Figure: Germline Organization of the Human Heavy Chain Locus. ~50 VH, ~20 DH, and 6 JH segments recombine (VH–DH–JH joining) to build the variable-region exon — a three-segment joining process unique to the heavy chain. The rearranged exon then lies upstream of a fixed, ordered array of CH genes (μ–δ–γ3–γ1–γ2b–γ2a–ε–α); which CH gene is spliced to the VHDJH exon determines the antibody's isotype.

6. The Molecular Mechanism of V(D)J Recombination

Somatic recombination of immunoglobulin gene segments — termed V(D)J recombination — is executed by a specialized DNA rearrangement mechanism that operates during early B-cell development.

Recombination Signal Sequences (RSSs)

DNA rearrangement is guided by highly conserved, non-coding DNA sequences flanking the V, D, and J coding segments, termed Recombination Signal Sequences (RSSs). An RSS consists of three conserved components.

5' 3' CODING SEGMENT (V, D, or J) HEPTAMER 5'-CACAGTG-3' (palindromic) SPACER 12 bp (one turn) or 23 bp (two turns) NONAMER 5'-ACAAAAACC-3' (AT-rich)

Figure: Anatomy of a Recombination Signal Sequence (RSS). Every V, D, and J coding segment is flanked by a conserved, palindromic heptamer (5'-CACAGTG-3') immediately adjacent to the coding sequence, and a conserved, AT-rich nonamer (5'-ACAAAAACC-3') at the outer end. The two are separated by a non-conserved spacer of exactly 12 bp (one DNA helical turn) or 23 bp (two helical turns), which sets the spacing of the recombinase machinery.

  • Component 1
    Heptamer

    A conserved, palindromic heptamer sequence (5'-CACAGTG-3') positioned immediately adjacent to the coding segment.

  • Component 2
    Nonamer

    An AT-rich, conserved nonamer sequence (5'-ACAAAAACC-3') positioned at the outer end.

  • Component 3
    Spacer

    An intervening, non-conserved spacer of either 12 base pairs (bp) or 23 base pairs (bp). These lengths correspond to one full turn (~12 bp) or two full turns (~23 bp) of the DNA double helix.

The 12/23 Rule (One-Turn / Two-Turn Rule)

Recombination can only occur between a segment flanked by a 12 bp spacer (one-turn RSS) and a segment flanked by a 23 bp spacer (two-turn RSS). This strictly enforces correct gene segment pairing.

  • κ Light Chain
    12 bp + 23 bp

    Vκ segments are flanked by a 12 bp RSS; Jκ segments are flanked by a 23 bp RSS (allowing direct V–J joining).

  • λ Light Chain
    23 bp + 12 bp

    Vλ segments are flanked by a 23 bp RSS; Jλ segments are flanked by a 12 bp RSS (allowing direct V–J joining).

  • Heavy Chain
    23 bp + 12 bp + 23 bp

    VH segments are flanked by a 23 bp RSS; JH segments are flanked by a 23 bp RSS. Crucially, the intermediate DH segments are flanked on both sides by a 12 bp RSS. Under the 12/23 rule, a 23 bp VH can only join to a 12 bp DH, and a 12 bp DH can only join to a 23 bp JH. This prevents direct VH–JH joining without a DH segment.

12/23 RULE — HEAVY CHAIN LOCUS ENFORCES V–D–J ORDER 23 + 23 → FORBIDDEN (same spacer length cannot pair) ✕ VH 23 bp RSS (3' side) DH 12 bp RSS (both sides) JH 23 bp RSS (5' side) 12+23 ✓ OK 12+23 ✓ OK

Figure: The 12/23 Rule at the Heavy Chain Locus. A segment flanked by a 23 bp (two-turn) RSS can only recombine with one flanked by a 12 bp (one-turn) RSS — never with another 23 bp segment. Because VH and JH are both flanked by 23 bp RSSs, they cannot join directly; the intervening DH segment, flanked on both sides by a 12 bp RSS, is compatible with both, forcing recombination through the obligatory VH–DH–JH order.

Steps of the V(D)J Recombination Pathway

The somatic rearrangement process is completed through a series of coordinated enzymatic steps.

V(D)J RECOMBINATION PATHWAY RECOGNITION & SYNAPSIS RAG1 · RAG2 · HMGB1 · HMGB2 SINGLE-STRAND NICKING RAG1 / RAG2 HAIRPIN & SIGNAL END FORMATION (Transesterification) CODING JOINT PATHWAY SIGNAL JOINT PATHWAY CODING ENDS (covalently sealed hairpins) HAIRPIN OPENING Artemis (activated by DNA-PKcs) P-NUCLEOTIDE GENERATION asymmetric hairpin resolution N-NUCLEOTIDE ADDITION TdT — template-independent DOUBLE-STRAND LIGATION (NHEJ) Ku70 · Ku80 · DNA-PKcs · Ligase IV/XRCC4→ Functional coding joint (rearranged V(D)J exon) SIGNAL ENDS (flat, blunt double-strand break) LIGATION OF SIGNAL JOINT excision circle (episome) — discardedNot retained in the final rearranged gene

Figure: The V(D)J Recombination Pathway. After RAG1/RAG2 (with HMGB1/HMGB2) synapse two compatible RSSs and nick the DNA, a transesterification reaction seals each coding end into a hairpin while leaving flat signal ends. The pathway then forks: signal ends are simply ligated head-to-head into a discarded excision circle, while coding ends require several additional steps — Artemis-mediated hairpin opening, P-nucleotide generation, TdT-catalyzed N-nucleotide addition, and finally NHEJ-mediated ligation — before becoming the functional, antigen-receptor-encoding coding joint.

  • Step 1
    Recognition and Synapsis

    The lymphoid-specific recombinases RAG1 and RAG2 (encoded by Recombination-Activating Genes 1 and 2) recognize and bind to the RSS heptamer and nonamer motifs. Together with the non-lymphoid, chromatin-bending proteins HMGB1 and HMGB2 (High Mobility Group B1 and B2), RAG1 and RAG2 bring two corresponding RSSs (one 12 bp and one 23 bp) into a stable synaptic complex.

  • Step 2
    DNA Cleavage and Hairpin Formation
    • Single-Strand Nick: RAG1 and RAG2 introduce a precise single-strand nick in the DNA at the 5' border of the heptamer, immediately adjacent to the coding sequence. This leaves a free 3'-hydroxyl (3'-OH) group on the coding strand.
    • Transesterification: the free 3'-OH group attacks the phosphodiester bond on the opposite (non-cleaved) DNA strand in a direct chemical transesterification reaction. This reaction forms a covalently sealed hairpin loop at the coding end and leaves a flat, double-stranded break at the signal end.
  • Step 3
    Signal Joint Formation

    The flat, double-strand signal ends are brought together and ligated in a precise head-to-head configuration to form a circular signal joint, which is discarded as an excision circle (episome).

  • Step 4
    Hairpin Opening and P-Nucleotide Addition
    • Artemis Cleavage: the covalently sealed hairpin loops on the coding ends must be opened. The lymphoid-specific endonuclease Artemis is recruited and activated via phosphorylation by the DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Artemis randomly cleaves the hairpin loop.
    • Palindromic (P) Nucleotides: if Artemis cleaves the hairpin asymmetrically, it leaves a single-stranded DNA overhang. Filling in this single-stranded tail with complementary nucleotides creates a short palindromic sequence at the coding joint, termed P-nucleotides.
  • Step 5
    N-Nucleotide Addition
    • TdT Catalysis: the enzyme Terminal Deoxynucleotidyl Transferase (TdT) template-independently adds up to 15 non-genomic nucleotides to the 3' ends of the opened coding strands. These randomly added bases are called N-nucleotides (non-templated).
    • Note: N-nucleotide addition occurs extensively during heavy chain recombination but is rare during light chain recombination, as TdT expression is downregulated during late B-cell developmental stages.
  • Step 6
    Ligation of the Coding Joint

    The processed coding ends are aligned. Unpaired nucleotides are removed by exonucleases, the gaps are filled in by DNA polymerases, and the final double-strand break is sealed via the Non-Homologous End Joining (NHEJ) pathway. This requires a multiprotein repair complex consisting of Ku70 and Ku80 (DNA end-binding proteins), DNA-PKcs, and the DNA Ligase IV / XRCC4 complex.

7. Productive vs. Non-Productive Rearrangements & Allelic Exclusion

Molecular Safeguards of V(D)J Joining

Because Artemis hairpin cleavage, exonuclease deletion, and TdT N-nucleotide addition are random processes, somatic recombination is highly imprecise.

  • 1 in 3
    Productive Rearrangement

    If the joining process preserves the correct triplet reading frame of the variable-region exon without introducing a premature stop codon, the rearrangement is productive.

  • 2 in 3
    Non-Productive Rearrangement

    If the joining process shifts the reading frame or introduces a premature stop codon, the rearrangement is non-productive and cannot yield a functional protein.

Allelic Exclusion

Each diploid B-cell precursor possesses two copies of each chromosome (one maternal and one paternal). However, B cells are strictly limited to expressing a single, unique heavy chain and a single, unique light chain specificity. This is termed allelic exclusion and operates on a feedback-loop mechanism.

  • 1
    Heavy Chain Selection

    Recombination initiates first at the heavy-chain locus on one chromosome. If the rearrangement is productive, the resulting μ heavy chain protein is expressed on the cell surface in complex with surrogate light chains, forming a pre-B-cell receptor (pre-BCR). This pre-BCR generates a survival and differentiation signal that actively suppresses and shuts down recombination at the heavy-chain locus of the second chromosome. If the rearrangement on the first chromosome is non-productive, the heavy-chain locus on the second chromosome undergoes recombination. If both chromosomes fail to yield a productive heavy chain, the cell undergoes programmed cell death (apoptosis).

HEAVY CHAIN ALLELIC EXCLUSION HEAVY-CHAIN LOCUS, ALLELE 1 rearranges productive (1/3) non-productive (2/3) μ CHAIN + SURROGATE L CHAINS → pre-BCR formed pre-BCR SUPPRESSES ALLELE 2 → PROCEED TO LIGHT CHAIN SELECTION HEAVY-CHAIN LOCUS, ALLELE 2 rearranges productive non-productive → PROCEED TO LIGHT CHAIN SELECTION APOPTOSIS both heavy-chain alleles failed

Figure: Heavy Chain Allelic Exclusion. A productive rearrangement on the first heavy-chain allele forms a pre-BCR whose signal shuts down recombination on the second allele. A non-productive first attempt permits the second allele to rearrange; only if both alleles fail does the pre-B cell die by apoptosis. Either productive outcome advances the cell to light chain selection.

  • 2
    Light Chain Selection

    Following a productive heavy chain rearrangement, light chain recombination begins, typically initiating first at the κ locus. If a productive Vκ–Jκ rearrangement occurs on the first chromosome, the resulting κ chain pairs with the μ heavy chain to express a functional IgM B-cell receptor (BCR), halting all further light chain recombination. If the first κ locus fails, the κ locus on the second chromosome rearranges. If both κ alleles fail, the cell initiates recombination at the λ locus on the first chromosome, and if necessary, the second λ locus. Only if all four light chain alleles fail to yield a productive joint does the cell die by apoptosis.

LIGHT CHAIN ALLELIC EXCLUSION CASCADE κ allele 1 rearranges κ allele 2 rearranges λ allele 1 rearranges λ allele 2 rearranges non-prod. non-prod. non-prod. productive productive productive productive✓ Functional IgM BCR — recombination halted ✓ Functional IgM BCR — recombination halted ✓ Functional IgM BCR — recombination halted ✓ Functional IgM BCR — recombination halted all 4 alleles non-productive APOPTOSIS all 4 light-chain alleles failed

Figure: Light Chain Allelic Exclusion Cascade. Light chain rearrangement is attempted sequentially — κ allele 1, then κ allele 2, then λ allele 1, then λ allele 2 — stopping the moment any allele produces a functional joint that pairs with the μ heavy chain to form a complete IgM BCR. Only if all four alleles fail does the B-cell precursor undergo apoptosis.

This sequential, feedback-regulated mechanism ensures that each mature B cell remains monoclonal and antigen-monospecific.

8. Generation of Antibody Diversity

Vertebrates utilize four primary molecular mechanisms to generate an immense diversity of antibody specificities.

1. Combinatorial V(D)J Joining

The random joining of different V, D, and J germ-line gene segments generates extensive diversity.

400 VL × 10 JL = 4,000 (4×103) functional light chains
400 VH × 10 DH × 10 JH = 40,000 (4×104) functional heavy chains

Mathematical model, assuming an organism with 400 V segments and 10 J segments for its light chains, and 400 V, 10 D, and 10 J segments for its heavy chains.

2. Junctional Diversification

Junctional diversification is the largest contributor to antibody diversity and is concentrated within the CDR3 loop.

  • Mechanism A
    Junctional Flexibility

    Imprecise joining caused by the random removal of nucleotides by exonucleases from the coding ends before ligation.

  • Mechanism B
    P-Nucleotide Addition

    The addition of palindromic nucleotides during asymmetric coding hairpin resolution by Artemis.

  • Mechanism C
    N-Nucleotide Addition

    The template-independent addition of random nucleotides by TdT at the junctions of the joined segments.

JUNCTIONAL DIVERSIFICATION AT THE V–D–J CODING JOINTS V SEGMENT (3' end) ✂ P N P D SEGMENT P N ✂ J SEGMENT (5' end) V/D/J segment Exonuclease-trimmed P-nucleotide N-nucleotide (TdT)

Figure: Junctional Diversification. At each coding joint, exonucleases first trim back the germline-encoded ends (junctional flexibility), Artemis's asymmetric hairpin resolution adds short palindromic P-nucleotides, and TdT then adds random, template-independent N-nucleotides. Together these processes make the exact junctional sequence — concentrated in CDR3 — essentially unpredictable from the germline segments alone.

3. Combinatorial Association of Heavy and Light Chains

Any independently rearranged heavy chain can pair with any independently rearranged light chain to form a complete, functional antibody molecule.

4,000 light chains × 40,000 heavy chains = 160,000,000 (1.6×108) unique antibodies
COMBINATORIAL DIVERSITY 400 VL × 10 JL = 4,000 LIGHT CHAINS 400 VH × 10 DH × 10 JH = 40,000 HEAVY CHAINS × 1.6 × 108 UNIQUE ANTIBODIES (4,000 light × 40,000 heavy combinatorial pairs)

Figure: Combinatorial Diversity from Segment Joining and Chain Pairing. Independent VL–JL and VH–DH–JH joining already yields 4,000 possible light chains and 40,000 possible heavy chains; because any rearranged heavy chain can pair with any rearranged light chain, the combinatorial repertoire multiplies to roughly 1.6×10⁸ distinct antibodies — before junctional diversification or somatic hypermutation are even considered.

4. Somatic Hypermutation (SHM) and Affinity Maturation

Unlike the three developmental mechanisms above, which occur in a germ-line, antigen-independent manner in the bone marrow, Somatic Hypermutation (SHM) occurs strictly after antigen exposure within the germinal centers of secondary lymphoid organs.

  • Rate
    ~1,000× Background Mutation Rate

    SHM introduces point mutations into the rearranged VH and VL exons at a rate of approximately 10-3 mutations per base pair per generation — roughly 10,000-fold higher than the normal background rate of somatic mutations in other host cells.

SOMATIC HYPERMUTATION — AID DEAMINATION & DNA REPAIR AID DEAMINATES C → U in single-stranded DNA exposed during transcription U:G MISMATCH a highly mutagenic lesion REPLICATION BASE EXCISION REPAIR (BER) MISMATCH REPAIR (MMR) Replication reads U as T before repair occurs A inserted opposite U → C:G to T:A transition (or G→A on complementary strand) Uracil DNA Glycosylase removes U → abasic (AP) site PCNA recruits error-prone translesion polymerases Transitions/transversions at the original C:G bp MMR machinery recognizes the U:G mismatch Exonucleases excise a patch of surrounding ssDNA Error-prone polymerases resynthesize → mutations at C:G site + neighboring A:TAll three pathways introduce point mutations into the rearranged VH / VL exon.

Figure: The Enzymatic Mechanism of Somatic Hypermutation. AID deaminates cytidine to uridine in transiently single-stranded DNA, creating a U:G mismatch. Depending on how the cell resolves this lesion — DNA replication reading through it, Base Excision Repair, or Mismatch Repair — different, error-prone outcomes introduce transition or transversion mutations at the original site and, for MMR, at neighboring base pairs as well.

  • Pathway 1
    Replication

    If the DNA replication machinery reads the U residue before repair, it inserts an adenine (A) on the newly synthesized strand, resulting in a C-to-T transition mutation (or a G-to-A transition on the complementary strand).

  • Pathway 2
    Base Excision Repair (BER)

    The enzyme Uracil DNA Glycosylase removes the uracil base, leaving an abasic (AP) site. The mismatch-repair accessory protein PCNA recruits error-prone, translesion DNA polymerases to fill the gap. These polymerases insert random nucleotides, creating transitions or transversions at the original C:G base pair.

  • Pathway 3
    Mismatch Repair (MMR)

    The mismatch-repair machinery recognizes the U:G mismatch. It recruits exonucleases to excise a patch of single-stranded DNA surrounding the mismatch and recruits error-prone polymerases to synthesize new DNA, introducing mutations at the C:G site and neighboring A:T bases.

Affinity Maturation: B-cell clones that acquire mutations that increase their receptor affinity are selectively expanded, while those with lower affinity undergo apoptosis. This antigen-driven process is termed affinity maturation.

In this lesson

LessonStep 14 of 28

Next quizImmunoglobulins: Structure, Classes and Antigenic Determinants
Scroll to Top